Alpine Bank Wealth Management’s Royalty Pharma RPRX Stock Holding History

Alpine Bank Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.6K	Buy	+82	New	+$4.27K	﹤0.01%	393
2025 Q4	–	Sell	-82	Closed	-$2.89K	–	345
2025 Q3	$2.89K	Hold	82	–	–	﹤0.01%	412
2025 Q2	$2.95K	Hold	82	–	–	﹤0.01%	406
2025 Q1	$2.55K	Buy	+82	New	+$2.6K	﹤0.01%	399
2024 Q3	$28.2K	Buy	+998	New	+$27.6K	﹤0.01%	326

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alpine Bank Wealth Management's RPRX Position: Q2 2026 in Review

Alpine Bank Wealth Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 82 shares worth $4.6K. The stake represents ﹤0.01% of the portfolio and ranks #393 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in RPRX as recently as Q3 2025.

Alpine Bank Wealth Management first reported a position in RPRX in Q3 2024 and has held it in 5 quarters since. The position peaked at $28.2K in Q3 2024. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Alpine Bank Wealth Management held 82 shares of Royalty Pharma worth $4.6K as of Q2 2026.
Royalty Pharma was a new Alpine Bank Wealth Management position in Q2 2026.
Royalty Pharma made up ﹤0.01% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #393 holding.
Alpine Bank Wealth Management first reported a position in Royalty Pharma in Q3 2024 and has held it in 5 quarters since.
Alpine Bank Wealth Management's Royalty Pharma position peaked at $28.2K in Q3 2024.
646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.